Life Sciences Advanced Technologies, Inc was founded in 1962 and was the first company in the world to manufacture AMV RT. AMV RT was later used in NASBA, RT-PCR and LAMP for research and development of many infectious diseases worldwide, such as HIV, HPV, Hepatitis, Pneumonia, Dengue virus, common flu virus etc.
As a world leader of research and development, we are proud of our NASBA technology for the benefit to life science research in the past 50 years. On this page, we selected a list of scientific publications in top international journals by our scientists and colleagues who use our AMV RT enzymes and NASBA for their research and development:
J Virol. 1978 Feb;25(2):546-52. Protein kinase from avian myeloblastosis virus. Houts GE, Miyagi M, Ellis C, Beard D, Watson KF, Beard JW. https://www.ncbi.nlm.nih.gov/pubmed/24125
J Virol. 1979 Feb;29(2):517-22. Reverse transcriptase from avian myeloblastosis virus. Houts GE, Miyagi M, Ellis C, Beard D, Beard JW. https://www.ncbi.nlm.nih.gov/pubmed/85721
Enhancing the Value of Molecular Methods to the Water Industry: An E. coli Case Study. Water Research Foundation http://www.waterrf.org/Pages/Projects.aspx?PID=4238
Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components. Keith Pardee, Alexander A. Green, Melissa K. Takahashi, …,David H. O’Connor, Lee Gehrke,James J. Collins.